- ►rcpe.ac.uk [PDF] JS Ross, KP Hill, DS Egilman, HM Krumholz - JAMA, 2008 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context Authorship in ... Cited by 97 - Related articles - BL Direct - All 9 versions
- ►washington.edu [PDF] CD DeAngelis, PB Fontanarosa - JAMA, 2008 - Am Med Assoc Two articles 1-2 in this issue of JAMA provide a glimpse of one company's
apparent misrepresentation of research data and its manipulation of clinical
research articles and clinical reviews; such information and articles ... Cited by 84 - Related articles - BL Direct - All 11 versions
PC Gotzsche, A Hróbjartsson, HK Johansen, … - PLoS Medicine, 2007 - medicine.plosjournals.org We conducted a cohort study comparing protocols and corresponding publications
for industry-initiated trials approved by the Scientific-Ethical Committees for
Copenhagen and Frederiksberg in 1994–1995. We defined ghost authorship as ... Cited by 70 - Related articles - Cached - BL Direct - All 14 versions
M Gazarian, M Kelly, JR McPhee, LV … - Medical Journal of Australia, 2006 - mja.com.au • Off-label prescribing is the prescription of a registered medicine for a use
that is not included in the product information. The practice is common, with
rates up to 40% in adults and up to 90% in paediatric patients. • ... Cited by 49 - Related articles - View as HTML - BL Direct - All 4 versions
- Free from Publisher KP Hill, JS Ross, DS Egilman, HM Krumholz - Annals of Internal Medicine, 2008 - Am Coll Physicians Background: Seeding trials, clinical studies conducted by pharmaceutical
companies that are designed to seem as if they answer a scientific question but
primarily fulfill marketing objectives, have not been described in detail. Cited by 25 - Related articles - All 6 versions
- ►oxfordjournals.org VKF Kong, MG Irwin - British Journal of Anaesthesia, 2007 - British Jrnl Anaesthesia Gabapentin is a second generation anticonvulsant that is effective in the
treatment of chronic neuropathic pain. It was not, until recently, thought to be
useful in acute perioperative conditions. However, a growing body of ... Cited by 15 - Related articles - BL Direct - All 17 versions
MA Steinman, GM Harper, M Chren, CS … - PLoS Medicine, 2007 - medicine.plosjournals.org Market research forms that describe detail visits for gabapentin became
available through litigation that alleged that gabapentin was promoted for
“off-label” uses. Forms were available for 97 physicians reporting on ... Cited by 14 - Related articles - Cached - BL Direct - All 9 versions
- ►192.70.175.129 [PDF] CS Landefeld, MA Steinman - New England Journal of Medicine, 2009 - content.nejm.org Dr. Hartzband is an endocrinologist at Beth Israel Deaconess Medical Center and
an as- sistant professor of medicine at Harvard Medical School, and Dr. Groopman
is a he- matologist–oncologist at Beth Israel Dea- coness Medical Center ... Cited by 12 - Related articles - All 9 versions
AS Kesselheim, J Avorn - The New England Journal of Medicine, 2008 - nejm.highwire.org In mid-February, the Food and Drug Adminis- tration (FDA) proposed a change in
its rules gov- erning pharmaceutical promotion that would wid- en the ability of
drug manufacturers to distribute information on unapproved uses of their ... Cited by 11 - Related articles - BL Direct - All 4 versions
